奇奇核170Re在束g谱学和176Ir EC/b+衰变研究

本论文在 166MeV 的束流能量下，利用重离子熔合蒸发反应 142 Nd（32 S， 1p3nγ ）170 Re 布居了 170 Re 的高自旋激发态，用 12 套带 BGO反康普顿抑制的高 纯锗探测器阵列进行了在束 X-γ 和γ γ − 符合测量。在 210MeV 的束流能量下， 利用重离子熔合蒸发反应 146 Nd（35 Cl，5nγ ）176 Ir 产生具有 β+ / EC 衰变性质的 核素 176 Ir, 由氦喷嘴快速带传输系统将反应产物送到低本底区，用一台小平面探 测器、一台轴对称型高纯锗探测器和一台 CLOVER 探测器进行了γ γ − 符合和 t γ − 单谱测量。基于这些测量结果，研究了 170 Re 的高自旋态和 176 Ir 的 β+ / EC 衰变性质。 本工作基于γ−γ符合关系及周围邻近核已知信息的综合分析，首次建立了包 括 16 个能级 26 条γ 跃迁的双奇核 170 Re 的转动带能级纲图，并利用推转壳模型、 粒子转子模型等对其进行了分析和讨论。根据实验提取出的准粒子顺排、 Routhian、旋称劈裂等结构信息和邻近双奇核带结构系统学知识的比较分析，指 出该带的两准粒子组态是 11/213/2 hi π ν ⊗ ，并且该带在低自旋出现旋称反转。 基于对 176 Ir 核 β+ / EC衰变实验数据的离线处理分析，对早先发表的 176 Ir 衰 变γ 跃迁进行确认的同时又发现了 4 个新能级和 13 条新的γ 射线，丰富了 176 Os 核的低位激发态能级纲图。根据典型γ 射线的衰变时间谱建议了 176 Ir核的一个长 寿命低自旋同核异能态，同时通过两准粒子耦合的半经验计算建议了其组态。

Study on the concentration and seasonal variation of inorganic elements in 35 species of marine algae

The concentrations of five major and 28 trace elements in 35 marine algae collected along the coast of China were determined by instrumental neutron activation analysis. The concentrations of halogens, rare earth elements and many transition metal elements in marine algae are remarkably higher than those in terrestrial plants. The concentration factors for 31 elements in all collected algae were calculated, those for tri- and tetra-valent elements were higher than those of the mono- and di-valent elements in marine algae. The biogeochemical characteristics of inorganic elements in marine algae were investigated. In addition, the seasonal variation of inorganic elements in Sargassum kjellmanianum was also studied. (C) 1998 Elsevier Science B.V. All rights reserved.

祁连山海北高寒草甸地区UV-B的气候变化特征

分析祁连山海北高寒草甸地区2002年太阳总辐射（Eg）、UV-B及UV-B占Eg比例的气候变化特征。结果表明：海北站地区UV-B较强，日瞬时最高接近10W•m^-2，日总量最高达0．204MJ•m^-2；日、年变化依Eg的日、年变化具有显著的正相关关系。UV-B与Eg的比值（η），不论是日变化还是年变化表现明显，一日间早晚低，中午高，一年间6月最高，冬季的12月低，与太阳高度角的变化具有一定的正相关关系。年平均η约为0．54％，植物生长期的5～9月约为0．65％。在海北高寒草甸地区Eg和UV-B的年总量分别达6387．436MJ•m^-2和35．981MJ•m^-2。

A importância da lignina para a produção de etanol de Segunda geração.

2010

Estabelecimento de estirpes de Bradyrhizobium japonicum/ B.elkanii e seus efeitos na reinoculacao da soja em solos de cerrado.

Neste trabalho sao apresentados os resultados de um estudo para avaliar o estabelecimento de estirpes de Bradyrhizobium japonicum / B. elkanii, na resposta da soja a reinoculacao em solos de Cerrado. O experimento, que teve duracao de seis anos, foi iniciado em 1994 num Latossolo Vermelho de primeiro cultivo, isento de populacoes de rizobio capazes de nodular a soja. O delineamento experimental foi o de blocos ao acaso com tres repeticoes e a cultivar de soja utilizada foi a Doko RC. A ocupacao dos nodulos foi avaliada por tecnicas de imuno-aglutinacao. No primeiro ano do experimento (safra 1993/1994), as estirpes CPAC 7, CPAC 15, 29W e SEMIA 587 (sorogrupos CB1809, SEMIA 566, 29W e SEMIA 587, respectivamente) foram introduzidas no solo por meio da inoculacao das sementes da soja Doko RC. Tambem foi incluido um tratamento sem inoculacao, com as parcelas cultivadas com arroz. No ano seguinte (safra 1994/1995), as parcelas foram subdivididas em tres subparcelas, e a soja foi cultivada sob tres tratamentos: a) CPAC 7, b) CPAC 15 e c) sem inoculacao. No terceiro ano (safra 1995/1996), todo o experimento recebeu a soja inoculada com a estirpe CPAC 7. No quarto e no quinto anos de conducao do experimento (safras 1997/1998 e 1998/1999), a soja foi cultivada sem inoculacao. No ano agricola 1996/1997 a area foi deixada em repouso. Para os tratamentos com inoculacao foram utilizados inoculantes turfosos (8,0 x 108 celulas/g) na proporcao de 1 kg de inoculante por 50 kg de sementes. As estirpes introduzidas no solo no primeiro ano influenciaram a ocorrencia da estirpe CPAC 7 nos nodulos obtidos no terceiro ano de conducao do experimento. Nos tratamentos onde a CPAC 7 foi introduzida no primeiro ano, sua ocorrencia nos nodulos foi, em media, de 70%, enquanto nos outros tratamentos variou entre 25% e 44%. No quarto e quinto anos, quando a soja foi cultivada sem inoculacao, estirpes do sorogrupo SEMIA 566 predominaram na nodulacao (mais de 44% dos nodulos). No quinto ano do experimento, mesmo nos tratamentos onde essa estirpe jamais foi inoculada, a ocorrencia do sorogrupo SEMIA 566 foi de 74% dos nodulos, evidenciando sua elevada capacidade competitiva. Futuras estrategias para reinoculacao da soja em solos de Cerrado com as estirpes CPAC 7 e CPAC 15 deverao levar as observacoes desse estudo em consideracao.

Informe técnico : análisis de pruebas físicas y cualidades de las arcillas 2 A- 2 B- 2 C- 2 D Veredea Palomitas - Floridablanca - Santander.

35 hojas : ilustraciones.

Impact of gene variants on sex-specific regulation of human Scavenger receptor class B type 1 (SR-BI) expression in liver and association with lipid levels in a population-based study.

BACKGROUND: Several studies have noted that genetic variants of SCARB1, a lipoprotein receptor involved in reverse cholesterol transport, are associated with serum lipid levels in a sex-dependent fashion. However, the mechanism underlying this gene by sex interaction has not been explored. METHODS: We utilized both epidemiological and molecular methods to study how estrogen and gene variants interact to influence SCARB1 expression and lipid levels. Interaction between 35 SCARB1 haplotype-tagged polymorphisms and endogenous estradiol levels was assessed in 498 postmenopausal Caucasian women from the population-based Rancho Bernardo Study. We further examined associated variants with overall and SCARB1 splice variant (SR-BI and SR-BII) expression in 91 human liver tissues using quantitative real-time PCR. RESULTS: Several variants on a haplotype block spanning intron 11 to intron 12 of SCARB1 showed significant gene by estradiol interaction affecting serum lipid levels, the strongest for rs838895 with HDL-cholesterol (p=9.2x10(-4)) and triglycerides (p=1.3x10(-3)) and the triglyceride:HDL cholesterol ratio (p=2.7x10(-4)). These same variants were associated with expression of the SR-BI isoform in a sex-specific fashion, with the strongest association found among liver tissue from 52 young women<45 years old (p=0.002). CONCLUSIONS: Estrogen and SCARB1 genotype may act synergistically to regulate expression of SCARB1 isoforms and impact serum levels of HDL cholesterol and triglycerides. This work highlights the importance of considering sex-dependent effects of gene variants on serum lipid levels.

Beam-target double-spin asymmetry A{LT} in charged pion production from deep inelastic scattering on a transversely polarized {3}He target at 1.4

We report the first measurement of the double-spin asymmetry A{LT} for charged pion electroproduction in semi-inclusive deep-inelastic electron scattering on a transversely polarized {3}He target. The kinematics focused on the valence quark region, 0.16

Four-decade responses of soil trace elements to an aggrading old-field forest: B, Mn, Zn, Cu, and Fe.

In the ancient and acidic Ultisol soils of the Southern Piedmont, USA, we studied changes in trace element biogeochemistry over four decades, a period during which formerly cultivated cotton fields were planted with pine seedlings that grew into mature forest stands. In 16 permanent plots, we estimated 40-year accumulations of trace elements in forest biomass and O horizons (between 1957 and 1997), and changes in bioavailable soil fractions indexed by extractions of 0.05 mol/L HCl and 0.2 mol/L acid ammonium oxalate (AAO). Element accumulations in 40-year tree biomass plus O horizons totaled 0.9, 2.9, 4.8, 49.6, and 501.3 kg/ha for Cu, B, Zn, Mn, and Fe, respectively. In response to this forest development, samples of the upper 0.6-m of mineral soil archived in 1962 and 1997 followed one of three patterns. (1) Extractable B and Mn were significantly depleted, by -4.1 and -57.7 kg/ha with AAO, depletions comparable to accumulations in biomass plus O horizons, 2.9 and 49.6 kg/ha, respectively. Tree uptake of B and Mn from mineral soil greatly outpaced resupplies from atmospheric deposition, mineral weathering, and deep-root uptake. (2) Extractable Zn and Cu changed little during forest growth, indicating that nutrient resupplies kept pace with accumulations by the aggrading forest. (3) Oxalate-extractable Fe increased substantially during forest growth, by 275.8 kg/ha, about 10-fold more than accumulations in tree biomass (28.7 kg/ha). The large increases in AAO-extractable Fe in surficial 0.35-m mineral soils were accompanied by substantial accretions of Fe in the forest's O horizon, by 473 kg/ha, amounts that dwarfed inputs via litterfall and canopy throughfall, indicating that forest Fe cycling is qualitatively different from that of other macro- and micronutrients. Bioturbation of surficial forest soil layers cannot account for these fractions and transformations of Fe, and we hypothesize that the secondary forest's large inputs of organic additions over four decades has fundamentally altered soil Fe oxides, potentially altering the bioavailability and retention of macro- and micronutrients, contaminants, and organic matter itself. The wide range of responses among the ecosystem's trace elements illustrates the great dynamics of the soil system over time scales of decades.

The role of B cells in solid organ transplantation.

The role of antibodies in chronic injury to organ transplants has been suggested for many years, but recently emphasized by new data. We have observed that when immunosuppressive potency decreases either by intentional weaning of maintenance agents or due to homeostatic repopulation after immune cell depletion, the threshold of B cell activation may be lowered. In human transplant recipients the result may be donor-specific antibody, C4d+ injury, and chronic rejection. This scenario has precise parallels in a rhesus monkey renal allograft model in which T cells are depleted with CD3 immunotoxin, or in a CD52-T cell transgenic mouse model using alemtuzumab to deplete T cells. Such animal models may be useful for the testing of therapeutic strategies to prevent DSA. We agree with others who suggest that weaning of immunosuppression may place transplant recipients at risk of chronic antibody-mediated rejection, and that strategies to prevent this scenario are needed if we are to improve long-term graft and patient outcomes in transplantation. We believe that animal models will play a crucial role in defining the pathophysiology of antibody-mediated rejection and in developing effective therapies to prevent graft injury. Two such animal models are described herein.

ENIGMA and the individual: Predicting factors that affect the brain in 35 countries worldwide.

In this review, we discuss recent work by the ENIGMA Consortium (http://enigma.ini.usc.edu) - a global alliance of over 500 scientists spread across 200 institutions in 35 countries collectively analyzing brain imaging, clinical, and genetic data. Initially formed to detect genetic influences on brain measures, ENIGMA has grown to over 30 working groups studying 12 major brain diseases by pooling and comparing brain data. In some of the largest neuroimaging studies to date - of schizophrenia and major depression - ENIGMA has found replicable disease effects on the brain that are consistent worldwide, as well as factors that modulate disease effects. In partnership with other consortia including ADNI, CHARGE, IMAGEN and others(1), ENIGMA's genomic screens - now numbering over 30,000 MRI scans - have revealed at least 8 genetic loci that affect brain volumes. Downstream of gene findings, ENIGMA has revealed how these individual variants - and genetic variants in general - may affect both the brain and risk for a range of diseases. The ENIGMA consortium is discovering factors that consistently affect brain structure and function that will serve as future predictors linking individual brain scans and genomic data. It is generating vast pools of normative data on brain measures - from tens of thousands of people - that may help detect deviations from normal development or aging in specific groups of subjects. We discuss challenges and opportunities in applying these predictors to individual subjects and new cohorts, as well as lessons we have learned in ENIGMA's efforts so far.

Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.

AIM: To evaluate pretreatment hepatitis B virus (HBV) testing, vaccination, and antiviral treatment rates in Veterans Affairs patients receiving anti-CD20 Ab for quality improvement. METHODS: We performed a retrospective cohort study using a national repository of Veterans Health Administration (VHA) electronic health record data. We identified all patients receiving anti-CD20 Ab treatment (2002-2014). We ascertained patient demographics, laboratory results, HBV vaccination status (from vaccination records), pharmacy data, and vital status. The high risk period for HBV reactivation is during anti-CD20 Ab treatment and 12 mo follow up. Therefore, we analyzed those who were followed to death or for at least 12 mo after completing anti-CD20 Ab. Pretreatment serologic tests were used to categorize chronic HBV (hepatitis B surface antigen positive or HBsAg+), past HBV (HBsAg-, hepatitis B core antibody positive or HBcAb+), resolved HBV (HBsAg-, HBcAb+, hepatitis B surface antibody positive or HBsAb+), likely prior vaccination (isolated HBsAb+), HBV negative (HBsAg-, HBcAb-), or unknown. Acute hepatitis B was defined by the appearance of HBsAg+ in the high risk period in patients who were pretreatment HBV negative. We assessed HBV antiviral treatment and the incidence of hepatitis, liver failure, and death during the high risk period. Cumulative hepatitis, liver failure, and death after anti-CD20 Ab initiation were compared by HBV disease categories and differences compared using the χ(2) test. Mean time to hepatitis peak alanine aminotransferase, liver failure, and death relative to anti-CD20 Ab administration and follow-up were also compared by HBV disease group. RESULTS: Among 19304 VHA patients who received anti-CD20 Ab, 10224 (53%) had pretreatment HBsAg testing during the study period, with 49% and 43% tested for HBsAg and HBcAb, respectively within 6 mo pretreatment in 2014. Of those tested, 2% (167/10224) had chronic HBV, 4% (326/7903) past HBV, 5% (427/8110) resolved HBV, 8% (628/8110) likely prior HBV vaccination, and 76% (6022/7903) were HBV negative. In those with chronic HBV infection, ≤ 37% received HBV antiviral treatment during the high risk period while 21% to 23% of those with past or resolved HBV, respectively, received HBV antiviral treatment. During and 12 mo after anti-CD20 Ab, the rate of hepatitis was significantly greater in those HBV positive vs negative (P = 0.001). The mortality rate was 35%-40% in chronic or past hepatitis B and 26%-31% in hepatitis B negative. In those pretreatment HBV negative, 16 (0.3%) developed acute hepatitis B of 4947 tested during anti-CD20Ab treatment and follow-up. CONCLUSION: While HBV testing of Veterans has increased prior to anti-CD20 Ab, few HBV+ patients received HBV antivirals, suggesting electronic health record algorithms may enhance health outcomes.

Review of household demand elasticities in Argentina

p.95-108